Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity

Supuran, 2013, Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture Supuran, 2008, Carbonic anhydrases: novel therapeutic applications for inhibitors and activators, Nat. Rev. Drug Discov., 7, 168, 10.1038/nrd2467 Capasso, 2014, Sulfa and trimethoprim-like drugs–antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors, J. Enzyme Inhib. Med. Chem., 29, 379, 10.3109/14756366.2013.787422 Supuran, 2017, Advances in structure-based drug discovery of carbonic anhydrase inhibitors, Expert Opin. Drug Discov., 12, 61, 10.1080/17460441.2017.1253677 Supuran, 2016, How many carbonic anhydrase inhibition mechanisms exist?, J. Enzyme Inhib. Med. Chem., 31, 345, 10.3109/14756366.2015.1122001 Neri, 2011, Interfering with pH regulation in tumours as a therapeutic strategy, Nat. Rev. Drug Discov., 10, 767, 10.1038/nrd3554 Supuran, 2018, Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?, J. Enzyme Inhib. Med. Chem., 33, 485, 10.1080/14756366.2018.1428572 Alterio, 2012, Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?, Chem. Rev., 112, 4421, 10.1021/cr200176r De Simone, 1804, Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target, Biochim. Biophys. Acta, 2010, 404 Pastorek, 2015, Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use, 52 Lou, 2011, Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors, Cancer Res., 71, 3364, 10.1158/0008-5472.CAN-10-4261 Pacchiano, 2011, Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis, J. Med. Chem., 54, 1896, 10.1021/jm101541x Congiu, 2014, Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N, N-disubstituted sulfanilamides incorporating 4, 4, 4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2 (3H)-one/thione moieties, Bioorg. Med. Chem. Lett., 24, 1776, 10.1016/j.bmcl.2014.02.030 Awadallah, 2015, Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives, Eur. J. Med. Chem., 96, 425, 10.1016/j.ejmech.2015.04.033 Awadallah, 2018, Inhibition studies on a panel of human carbonic anhydrases with N 1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails, J. Enzym. Inhib. Med. Chem., 33, 629, 10.1080/14756366.2018.1446432 Abdel Gawad, 2016, Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines, Bioorg. Med. Chem., 24, 3043, 10.1016/j.bmc.2016.05.016 Georgey, 2019, 1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity, Bioorg. Chem., 82, 109, 10.1016/j.bioorg.2018.09.037 Eldehna, 2019, Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents, Eur. J. Med. Chem., 162, 147, 10.1016/j.ejmech.2018.10.068 Eldehna, 2018, Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro anticancer activity towards colon cancer, Bioorg. Med. Chem., 81, 425, 10.1016/j.bioorg.2018.09.007 Eldehna, 2017, Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies, Eur. J. Med. Chem., 139, 250, 10.1016/j.ejmech.2017.07.073 Ingersoll, 1932, Hippuric acid, Org. Synth., 40 Jun, 1893, Ueber die Condensation der Hippursäure mit Phtalsäureanhydrid und mit Benzaldehyd, Justus Liebigs Annalen der Chemie, 275, 1, 10.1002/jlac.18932750102 Acheson, 1960, 694. The synthesis of some acylglycines and related oxazolones, J. Chem. Soc. (Resumed), 3457, 10.1039/jr9600003457 Cleary, 2010, Catalyzing the Erlenmeyer Plöchl reaction: organic bases versus sodium acetate, Tetrahedron Lett., 51, 1533, 10.1016/j.tetlet.2009.11.125 Khalifah, 1971, The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C, J. Biol. Chem., 246, 2561, 10.1016/S0021-9258(18)62326-9 Skehan, 1990, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst., 82, 1107, 10.1093/jnci/82.13.1107 Eldehna, 2016, Synthesis and cytotoxic activity of biphenylurea derivatives containing indolin-2-one moieties, Molecules, 21, 762, 10.3390/molecules21060762 Eldehna, 2019, Eur. J. Med. Chem., 163, 37, 10.1016/j.ejmech.2018.11.061 Trastour, 2007, HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome, Int. J. Cancer., 120, 1451, 10.1002/ijc.22436 Alafeefy, 2016, Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents, Eur. J. Med. Chem., 109, 247, 10.1016/j.ejmech.2016.01.001 Korkeila, 2009, Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer, Br. J. Cancer., 100, 874, 10.1038/sj.bjc.6604949 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Nocentini, 2016, Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations, J. Med. Chem., 59, 10692, 10.1021/acs.jmedchem.6b01389 Leitans, 2015, Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX, J. Med. Chem., 58, 9004, 10.1021/acs.jmedchem.5b01343 Conway, 2009, A simple and efficient method for the synthesis of Erlenmeyer azlactones, Tetrahedron, 65, 2935, 10.1016/j.tet.2009.02.011 Parveen, 2013, Synthesis, bioassay, crystal structure and ab initio studies of Erlenmeyer azlactones, Spectrochim. Acta A Mol. Biomol. Spectrosc., 104, 538, 10.1016/j.saa.2012.11.054 Abo-Ashour, 2019, Novel synthesized SLC-0111 thiazole and thiadiazole analogues: determination of their carbonic anhydrase inhibitory activity and molecular modeling studies, Bioorg. Chem., 87, 794, 10.1016/j.bioorg.2019.04.002 Eldehna, 2019, SLC-0111 enaminone analogues, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX, Bioorg. Chem., 83, 549, 10.1016/j.bioorg.2018.11.014 Ibrahim, 2018, Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform, Eur. J. Med. Chem., 152, 1, 10.1016/j.ejmech.2018.04.016 Abo-Ashour, 2018, Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies, Eur. J. Med. Chem., 157, 28, 10.1016/j.ejmech.2018.07.054 Fares, 2017, Synthesis of bulky-tailed sulfonamides incorporating pyrido [2, 3-d][1, 2, 4] triazolo [4, 3-a] pyrimidin-1 (5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects, Bioorg. Med. Chem., 25, 2210, 10.1016/j.bmc.2017.02.037 Monks, 1991, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst., 83, 757, 10.1093/jnci/83.11.757 Boyd, 1995, Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen, Drug Dev. Res., 34, 91, 10.1002/ddr.430340203 M.R. Boyd, in: B.A. Teicher (Ed.), Cancer Drug Discovery and Development: Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials and Approval, second ed., Humana Press, Totowa, NJ, USA, 2014, pp. 41-62 (Chapter 1). Abo-Ashour, 2018, Novel indole-thiazolidinone conjugates: design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents, Eur. J. Med. Chem., 160, 49, 10.1016/j.ejmech.2018.10.008 Eldehna, 2019, Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents, J. Enzym. Inhib. Med. Chem., 34, 322, 10.1080/14756366.2018.1547286 Ismail, 2018, Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells, Eur. J. Med. Chem., 155, 782, 10.1016/j.ejmech.2018.06.024 Almahli, 2018, Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer, Bioorg. Chem., 77, 443, 10.1016/j.bioorg.2018.01.034 Eldehna, 2018, One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDAMB-231 cells, J. Enzym. Inhib. Med. Chem., 33, 309, 10.1080/14756366.2017.1417276 Sabt, 2018, Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies, J. Enzym. Inhib. Med. Chem., 33, 1095, 10.1080/14756366.2018.1477137 Eldehna, 2018, Novel [(3-indolylmethylene) hydrazono] indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation, J. Enzym. Inhib. Med. Chem., 33, 686, 10.1080/14756366.2017.1421181 Eldehna, 2017, Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents, J. Enzym Inhib. Med. Chem., 32, 600, 10.1080/14756366.2017.1279155 Schrödinger Suite Release 2018-2, Schrödinger, LLC, New York, NY, 2018: (a) Maestrov.11.6; (b) Epik, v.4.4; (c) Impact, v.7.9; (d) Prime, v.5.2; (e) Macromodel v.12.0. (f) Glide, v.7.9. Nocentini, 2019, Phosphorus versus sulfur: discovery of benzenephosphonamidates as versatile sulfonamide-mimic chemotypes acting as carbonic anhydrase inhibitors, Chemistry., 25, 1188, 10.1002/chem.201805039 Nocentini, 2018, Supuran CT steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms, J. Enzyme Inhib. Med. Chem., 33, 1453, 10.1080/14756366.2018.1512597 Nocentini, 2018, Deciphering the mechanism of human carbonic anhydrases inhibition with sulfocoumarins: computational and experimental studies, Chemistry, 24, 7840, 10.1002/chem.201800941